Development of novel drug-delivery nanocarriers directed to dodge potential drug resistance mechanisms using a 3D crosstalk model of pancreatic adenocarcinoma cells and its associated stroma (NanoPan-3D).

Projecte: Ajuts a projectesRecerca

Detalls del projecte

AcrònimNanoPan-3D
EstatusActiu
Data efectiva d'inici i finalització1/09/2231/08/25

Finançament

  • Agencia Estatal de Investigación: 217.800,00 €